PMA-ddPCR Bacterial Viability Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for quantifying bacterial viability are inaccurate, particularly for low biomass samples, and fail to provide absolute quantification, leading to issues with DNA signal-to-noise ratios and non-linear results in quantitative PCR.
Innovation Solution
A method involving the use of propidium monoazide (PMA) to differentiate between live and dead bacterial DNA, combined with droplet-digital PCR (ddPCR) for absolute viability determination by comparing DNA quantities in treated and untreated subsamples, using gene-specific primers for precise quantification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard quantitative PCR is used to quantify bacterial DNA, then amplification of bacterial DNA is achieved, but the results are non-linear and DNA signal-to-noise ratios are poor
Solution Approach 1:
The patent replaces standard quantitative PCR (a continuous amplification system) with droplet-digital PCR (a partitioned system). By dividing the sample into thousands of individual droplets, each containing 0 or 1 bacterial cell, the system transforms the continuous quantitative measurement problem into discrete countable units, enabling absolute quantification without standard curves and achieving linear, reliable results
Solution Approach 2:
The patent segments the bacterial sample into thousands of individual droplets using microfluidics. This segmentation allows each droplet to be independently analyzed, with binary outcomes (presence/absence of bacterial DNA), transforming the measurement into a countable statistical process that provides absolute quantification and eliminates the non-linearity issues of conventional qPCR
2Quantity of substance
If DNA extraction is performed on mixed live-dead bacterial samples, then total bacterial DNA is obtained, but live and dead cell DNA cannot be distinguished
Solution Approach 1:
The patent introduces propidium monoazide (PMA) as an intermediary substance that selectively binds to DNA from dead cells. PMA penetrates only compromised cell membranes, binds to DNA, and upon light activation forms covalent crosslinks that prevent PCR amplification. This intermediary enables differential treatment of live versus dead cell DNA, allowing viability status to be preserved through the extraction and amplification process
Solution Approach 2:
The patent converts the harmful effect of cell death (membrane compromise) into a beneficial selective marker. Dead cells with compromised membranes allow PMA entry and DNA binding, while live cells with intact membranes exclude PMA. This transforms the negative attribute of cell death into a positive identification feature that enables selective amplification of live cell DNA
3Productivity
If conventional viability methods are used, then bacterial quantification is achieved, but absolute viability determination is inaccurate
Solution Approach 1:
The patent performs preliminary enrichment of bacterial cells from complex environmental samples using selective culture conditions or filtration before DNA extraction. This preliminary action increases the concentration of target bacteria and removes inhibitors, enabling accurate detection and quantification even in low-biomass samples while maintaining the ability to distinguish viable from non-viable cells
Solution Approach 2:
The patent uses PMA as a mediator that selectively interacts with dead cell DNA, and uses the ratio of PMA-treated to untreated DNA signals as an intermediary metric to calculate absolute viability percentages. This intermediary measurement approach provides accurate absolute viability determination while maintaining high throughput
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides accurate, absolute quantification of bacterial viability, effectively distinguishing between live and dead cells, even at low biomass levels, and accurately assesses bacterial community structure changes over time or location.
Implementation Method 1
the PMA may then be activated and cross-linked by exposing the first subsample to blue light wavelengths for a second period of time
Data Source
AI summary
A highly reliable and accurate method of assessing bacterial community viability has been developed that allows for the assessment of extremely low biomass samples, which cannot be done with traditional methods, such as qPCR. The method utilizes both PMA and droplet digital PCR (PMA-ddPCR), resulting in very accurate quantification of DNA even at very low abundances. Comparing DNA abundance in untreated samples to DNA abundance in PMA-treated samples allows the calculation of the overall viability of bacteria in any given sample. Further, PMA can be combined with traditional RNA gene sequencing (using gene-specific primers for a target species or strain) to accurately profile, e.g., the human skin microbiome, which has previously been done using traditional sequencing methods alone, but this method allows for a species-level understanding of the viable (and nonviable) components of any complex bacterial community.